Porf. Percy P. Lee

City of Hope, USA

Email: [email protected]

Qualifications

1998 M.D., Harvard Medical School, Health Science and Technology

1994 B.Sc., Johns Hopkins University, Biomedical Engineering

Publications (selected)

1. Florez, N., Patel, S., Wakelee, H. A., et al. (2025). Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024. CANCER, 131(17), e70060.
2. Saad, M. B., Al-Tashi, Q., Hong, L. Z., et al. (2025). Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC. NATURE COMMUNICATIONS, 16(1), 6828.
3. Kennedy, T., Singh, S., Abood, G., et al. (2025). Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines. CANCER MEDICINE, 14(14), e71043.
4. Eustace, N., Amini, A., Malhotra, J., et al. (2025). Stereotactic body radiation therapy in the management of lung neoplasms: is it ready for prime time? CURRENT OPINION IN PULMONARY MEDICINE, 31(4), 326–334.
5. Odwuor, A., Lee, P. R. Y., Chang, J. Y., et al. (2025). Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. CLINICAL LUNG CANCER, 26(5), 384–392.
6. Ladbury, C., Sidiqi, B., Cantrell, N., et al. (2025). Stereotactic Body Radiation Therapy for Primary Lung Cancer and Metastases: A Case-Based Discussion on Challenging Cases. PRACTICAL RADIATION ONCOLOGY, 15(3), 262–276.
7. Averett, L., Lee, P. R. Y., & Massarelli, E. (2025). Things You Should Know About the Multimodal Treatment of SCLC. ONCOLOGY-NEW YORK, 39(4).
8. Gombrich, W., Eustace, N., Liu, Y. F., et al. (2025). Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative Radiotherapy. CANCERS, 17(7), 1233.
9. Williams, V. M., Hallemeier, C. L., Jethwa, K. R., et al. (2025). Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 48(4), 163–179.
10. Kassardjian, A. A., Malhotra, J., & Lee, P. (2025). Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm. TRANSLATIONAL CANCER RESEARCH, 14(1), 11–15.
11. Malhotra, J., Huang, A., Amini, A., et al. (2024). Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors. CANCERS, 16(21), 3603.
12. Ning, MS., Odwuor, A., Chang, J. Y., et al. (2024). Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. CANCERS, 16(21), 3587.
13. Liu, J. S., Sidiqi, B., McComas, K., et al. (2024). SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases. PRACTICAL RADIATION ONCOLOGY, 14(6), 555–573.
14. Anker, C. J., Tchelebi, L. T., Selfridge, J. E., et al. (2024). Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 120(4), 946–977.
15. Anker, C., Tchelebi, L., Selfridge, J., et al. (2024). American Radium Society Appropriate Use Criteria for Non-Operative Management (NOM) of Rectal Adenocarcinoma: Systematic Review and Guidelines. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 47(10), S48.
16. Jethwa, K., Kim, E., Berlin, J., et al. (2024). Executive Summary of the American Radium Society® Appropriate Use Criteria for Neoadjuvant Therapy for Non-Metastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 47(10), S35.
17. Tchelebi, L., Jethwa, K., Levy, A., et al. (2024). American Radium Society® (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 47(10), S30.
18. Chen, X. R., Weng, J. K., Sobremonte, A., et al. (2024). Case report: Cardiac neuroendocrine carcinoma and squamous cell carcinoma treated with MR-guided adaptive stereotactic radiation therapy. FRONTIERS IN ONCOLOGY, 14, 1411474.
19. Malhotra, J., De, S., Nguyen, K., et al. (2024). Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors. CANCER IMMUNOLOGY IMMUNOTHERAPY, 73(11), 234.
20. Florez, N., Patel, S. P., Wakelee, H., et al. (2024). Proceedings of the 1st biannual bridging the gaps in lung cancer conference. ONCOLOGIST, 30(2).

Profile Details
https://www.cityofhope.org/patients/find-a-doctor/percy-lee
https://scholar.google.com/citations?user=l0fch9kAAAAJ&hl=en
https://rocketreach.co/percy-lee-email_9500528

WOS ResearcherID: FHV-7212-2022